UniProt ID | ACL6A_MOUSE | |
---|---|---|
UniProt AC | Q9Z2N8 | |
Protein Name | Actin-like protein 6A | |
Gene Name | Actl6a | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 429 | |
Subcellular Localization | Nucleus . | |
Protein Description | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Required for maximal ATPase activity of SMARCA4/BRG1/BAF190A and for association of the SMARCA4/BRG1/BAF190A containing remodeling complex BAF with chromatin/nuclear matrix. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and is required for the proliferation of neural progenitors. During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth. [PubMed: 17640523 Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Putative core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair (By similarity] | |
Protein Sequence | MSGGVYGGDEVGALVFDIGSYTVRAGYAGEDCPKVDFPTAIGVVLERDDGSTMMEIDGDKGKQGGPTYYIDTNALRVPRENMEAISPLKNGMVEDWDSFQAILDHTYKMHVKSEASLHPVLMSEAPWNTRAKREKLTELMFEHYSIPAFFLCKTAVLTAFANGRSTGLILDSGATHTTAIPVHDGYVLQQGIVKSPLAGDFITMQCRELFQEMNIELIPPYMIASKEAVREGSPANWKRKEKLPQVTRSWHNYMCNCVIQDFQASVLQVSDSTYDEQVAAQMPTVHYEFPNGYNCDFGAERLKIPEGLFDPSNVKGLSGNTMLGVSHVVTTSVGMCDIDIRPGLYGSVIVAGGNTLIQSFTDRLNRELSQKTPPSMRLKLIANNTTVERRFSSWIGGSILASLGTFQQMWISKQEYEEGGKQCVERKCP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSGGVYGGD ------CCCCCCCCC | 44.23 | - | |
6 | Phosphorylation | --MSGGVYGGDEVGA --CCCCCCCCCCCCE | 20.75 | 30387612 | |
52 | Phosphorylation | LERDDGSTMMEIDGD EECCCCCEEEEECCC | 26.51 | 22871156 | |
62 | Ubiquitination | EIDGDKGKQGGPTYY EECCCCCCCCCCEEE | 52.06 | - | |
68 | Phosphorylation | GKQGGPTYYIDTNAL CCCCCCEEEEECCCC | 11.10 | 22871156 | |
69 | Phosphorylation | KQGGPTYYIDTNALR CCCCCEEEEECCCCC | 8.52 | 22871156 | |
86 | Phosphorylation | RENMEAISPLKNGMV HHHHHHHCCCCCCCC | 31.09 | 28066266 | |
129 | Phosphorylation | MSEAPWNTRAKREKL HCCCCCCHHHHHHHH | 28.30 | - | |
221 | Phosphorylation | NIELIPPYMIASKEA CCHHCCCCCEECHHH | 8.87 | - | |
225 | Phosphorylation | IPPYMIASKEAVREG CCCCCEECHHHHHCC | 21.80 | - | |
233 | Phosphorylation | KEAVREGSPANWKRK HHHHHCCCCCCCCCH | 18.98 | 26824392 | |
242 | Ubiquitination | ANWKRKEKLPQVTRS CCCCCHHHCCCCCHH | 69.38 | - | |
303 | Ubiquitination | DFGAERLKIPEGLFD CCCCHHCCCCCCCCC | 63.54 | - | |
379 | Acetylation | TPPSMRLKLIANNTT CCCHHHEEEHHCCCC | 27.73 | 22826441 | |
379 | Malonylation | TPPSMRLKLIANNTT CCCHHHEEEHHCCCC | 27.73 | 26320211 | |
398 | Phosphorylation | FSSWIGGSILASLGT HHHHHHHHHHHHHCH | 14.82 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ACL6A_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ACL6A_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ACL6A_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ACL6A_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...